A limiting challenge remains the complexity of rare disease development and a rapidly evolving landscape.

Our Exhibitor-Hosted Session "Regulatory Acceptance of NAMs in Human Health Safety Testing of Agrochemicals and Industrial Chemicals"

The International Council for Harmonization of Technical Requirements for Pharmaceuticals for Human Use issued draft guidance on ICH Q14 in March 2022.

Labcorp Biopharmaceutical CMC Services has been at the forefront of implementing ICH Q14 guidelines and using risk-based approaches around QbD for CMC services.

This webinar focuses on non-invasive approaches to NAFLD/NASH drug development. During the webinar, speakers will provide updates on current and emerging NASH biomarkers, which are also anticipated to be important tools in clinical practice.